January 14, 2023
1 min read
Cervical Cancer Awareness Month is observed every January.
An estimated 14,100 new cases of invasive cervical cancer are diagnosed in the United States annually, and approximately 4,280 women will die of the disease this year, according to American Cancer Society.
Cervical Cancer Awareness Month helps educate the public on the malignancy, which is highly preventable through HPV vaccination and appropriate screening.
In conjunction with the observation, Healio provides the following updates in cervical cancer prevention, screening, diagnosis and treatment.
1. Treatment of advanced, recurrent and metastatic cervical cancer has come a long way in the past 15 years, and data on novel combinations and therapies provide hope for further progress, according to a speaker at Chemotherapy Foundation Symposium. Read more.
2. Remote interventions led to higher screening rates for cervical cancer and other malignancies among women who live in rural areas. Read more.
3. Minimally invasive surgery conferred lower survival rates than open surgery among women with cervical cancer, phase 3 trial results showed. Read more.
4. Assessment of sexual function occurred far less often among women undergoing brachytherapy for cervical cancer than men who received the internal radiotherapy for prostate cancer. Read more.
5. Atezolizumab (Tecentriq, Genentech) administered before and during chemoradiation appeared safe and demonstrated immune-modulating activity among women with node-positive locally advanced cervical cancer. Read more.
6. Rates of distant-stage cervical cancer increased among certain women in the United States between 2001 and 2018. At the same time, rates of early-stage cervical cancer decreased. Read more.
7. Individuals who identified as a sexual minority had lower odds of ever undergoing Pap testing than heterosexual individuals. The findings appeared consistent across specific sexual minority groups. Read more.
8. A decrease in cervical cancer rates in the United States among younger women, may be associated with HPV vaccination approval. Read more.
